EP3957752
TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS HAVING RISK ALLELES IN THE GENES ENCODING IL33 AND IL1RL1
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.3.2018EP published:
20.8.2025EP application number:
21162316.0
EPO information:
European Patent Register
Max expiry date:
19.3.2038
Title in English:
TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS HAVING RISK ALLELES IN THE GENES ENCODING IL33 AND IL1RL1Language of the patent:
English
Timeline
Today
20.3.2018EP application
20.8.2025EP Publication
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
BRUSE, ShannonAddress:
Tarrytown, New York 10591, US
Name:
MCCARTHY, ShaneAddress:
Tarrytown, New York 10591, US
Name:
BARAS, ArisAddress:
Tarrytown, New York 10591, US
Name:
DEWEY, FrederickAddress:
Tarrytown, New York 10591, US
Name:
GOTTESMAN, OmriAddress:
Tarrytown, New York 10591, US
Priority
Number:
201762485077 PDate:
13.4.2017Country:
US
Classification
Categories:
C12Q 1/6883